🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Evolution of Lumbar Spine Movement Fluidity Using Xsens Inertial Sensors in Subjects With Chronic Low Back Pain Before and After Rehabilitation

RecruitingNAAges 18 Years - 65 YearsAllUniversity Hospital, Montpellier
NCT07327554 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Low back pain, defined as pain located between the thoracolumbar junction and the lower gluteal fold, becomes chronic in 8% of patients. As the leading cause of disability worldwide, it has major individual and medico-economic consequences. Three-dimensional biomechanical analysis allows exploration of movement alterations related to low back pain. Although several parameters have already been studied (maximum joint range of motion (ROM), lumbopelvic rhythm, movement variability, gait), no consistent kinematic profile has emerged. Movement fluidity, assessed by the presence of jerks (brief movement disturbances), remains under-described despite its relevance in evaluating movement quality. Invistigators hypothesize that lumbar spine movement fluidity during flexion improves after a rehabilitation program and correlates with clinical response. This project stands out by exploring a rar

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years inclusive * BMI between 18-30 kg/m² * Chronic low back pain lasting more than three months * Rehabilitation care in the Physical Medicine and Rehabilitation Department of Montpellier University Hospital Exclusion Criteria: * Sciatica episode within the last three months * Traumatic, tumoral, or infectious cause of low back pain * History of spinal, pelvic, or hip fracture * Inflammatory rheumatism * Lumbar arthrodesis * Severe scoliosis * Subject with a legal protection measure (guardianship, curatorship) * Subject under legal protection * Subject not affiliated to a social security system or not benefiting from such a system * Absence of informed written consent * Pregnant or breastfeeding women
💊

What it tests

  • X-sens sensor
📍

Where

1 site
University Hospital of Montpellier
Montpellier, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy